News

Filter

Current filters:

Strattera

1 to 9 of 56 results

Eli Lilly exceeds expectations with third quarter results

Eli Lilly exceeds expectations with third quarter results

24-10-2013

US pharma major Eli Lilly has announced financial results for the third quarter of 2013. Despite the…

AlimtaAmyvidAxironCialisCymbaltaEffientEli LillyEvistaFinancialForteoHumalogNorth AmericaPharmaceuticalStratteraTrajentaZyprexa

Eli Lilly records higher than expected earnings in 2nd-qtr results

24-07-2013

US drug major Eli Lilly's (NYSE: LLY) recorded higher than expected earnings as growth in key products…

AlimtaCialisCymbaltaEffientEli LillyEvistaFinancialForteoHumalogNorth AmericaPharmaceuticalStratteraZyprexa

Shire's Elvanse shows significantly faster response in ADHD symptoms than Strattera

07-06-2013

Ireland-headquartered Shire (LSE: SHP, NASDAQ: SHPG) presented positive scientific data comparing the…

Eli LillyElvanseNeurologicalPharmaceuticalResearchShireStrattera

US FDA advisory panel narrowly votes to expand use of Eli Lilly’s Cymbalta for pain

20-08-2010

In a decision that was not widely expected given ongoing liver damage concerns, a US Food and Drug Administration…

CymbaltaEli LillyLegalNeurologicalNorth AmericaPharmaceuticalRegulationStrattera

Court rules against Eli Lilly in patent dispute over Strattera, but drug major will appeal

16-08-2010

US drug major Eli Lilly suffered a blow last week, when the US District Court for the District of New…

Eli LillyGenericsNeurologicalNorth AmericaPatentsPharmaceuticalStrattera

1 to 9 of 56 results

COMPANY SPOTLIGHT

Menarini

Back to top